Register for course

Speaker: Dr. Nelson L. Rhodus
University of Minnesota

Abstract: Oral cancer is one of the most treatable of the major cancers when discovered and treated early. Yet oral cancer (the sixth most common cancer in the world) is the only major cancer who’s incidence is rising when all other cancers are declining. Dental professionals are uniquely positioned to screen patients and detect oral cancer in its early, treatable stage. The identification of both oral cancer as well as precancerous lesions and how best to examine for and diagnosis them is presented. Although the gold standard for diagnosis is a biopsy and histopathology, new diagnostic adjunctive imaging technologies, as well as developing genetic and proteomic biomarkers hold promise for earlier detection.

Learning Objectives:

At the conclusion of this course, participants will be able to:

1. Review the epidemiology, pathophysiology and clinical presentation of oral cancer as well as pre- cancerous lesions
2. Present evidences- based clinical techniques for examining and detecting oral cancer as well as pre-cancerous lesions
3. Familiarize professionals with the latest techniques in oral screening, both aided and unaided.
4. Assist practitioners in communicating the need for oral cancer screening to their patients.

Tuition: $59/1.5 ADA CERP credit hour

Course Prerequisites: None required 
Course Format: Virtual Lecture
Conflict of Interest: None reported by speaker
Contact: Caitlin Laughlin at caitlin_laughlin@hsdm.harvard.edu
Cancellation Policy: Cancellation 7 days before the course will be eligible for full refund. No refund will be made within 7 days of the course initiation date.